[HTML] springer.comFull View

[HTML][HTML] Prevalence and clinicopathological associations of HER2 expression in non-small cell lung cancer: a retrospective study in Jordanian patients

O Abu Al Karsaneh, A Al Anber, M ALQudah… - Diagnostic …, 2023 - Springer
Background Human epidermal growth factor receptor 2 (HER2), a promising therapeutic
target, can be mutated, amplified, or overexpressed in different malignancies, including non …
被引用次数：3 相关文章

Prevalence and clinicopathological associations of HER2 expression in non-small cell lung cancer: a retrospective study in Jordanian patients.

O Abu Al Karsaneh, A Al Anber, M ALQudah… - Diagnostic …, 2023 - europepmc.org
Background Human epidermal growth factor receptor 2 (HER2), a promising therapeutic
target, can be mutated, amplified, or overexpressed in different malignancies, including non …

Prevalence and clinicopathological associations of HER2 expression in non-small cell lung cancer: a retrospective study in Jordanian patients.

O Abu Al Karsaneh, A Al Anber… - Diagnostic …, 2023 - search.ebscohost.com
Background: Human epidermal growth factor receptor 2 (HER2), a promising therapeutic
target, can be mutated, amplified, or overexpressed in different malignancies, including non …

Prevalence and clinicopathological associations of HER2 expression in non-small cell lung cancer: a retrospective study in Jordanian patients

OA Al Karsaneh, A Al Anber… - Diagnostic …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Human epidermal growth factor receptor 2 (HER2), a promising therapeutic
target, can be mutated, amplified, or overexpressed in different malignancies, including non …
[HTML] biomedcentral.com

[HTML][HTML] Prevalence and clinicopathological associations of HER2 expression in non-small cell lung cancer: a retrospective study in Jordanian patients

O Abu Al Karsaneh, A Al Anber… - Diagnostic …, 2023 - diagnosticpathology.biomedcentral …
Human epidermal growth factor receptor 2 (HER2), a promising therapeutic target, can be
mutated, amplified, or overexpressed in different malignancies, including non-small cell lung …
[HTML] nih.gov

[HTML][HTML] Prevalence and clinicopathological associations of HER2 expression in non-small cell lung cancer: a retrospective study in Jordanian patients

OA Al Karsaneh, A Al Anber, M ALQudah… - Diagnostic …, 2023 - ncbi.nlm.nih.gov
Background Human epidermal growth factor receptor 2 (HER2), a promising therapeutic
target, can be mutated, amplified, or overexpressed in different malignancies, including non …

Prevalence and clinicopathological associations of HER2 expression in non-small cell lung cancer: a retrospective study in Jordanian patients

OA Al Karsaneh, A Al Anber, M ALQudah… - Diagnostic …, 2023 - search.proquest.com
Background Human epidermal growth factor receptor 2 (HER2), a promising therapeutic
target, can be mutated, amplified, or overexpressed in different malignancies, including non …
[PDF] biomedcentral.com

[PDF][PDF] Prevalence and clinicopathological associations of HER2 expression in non-small cell lung cancer: a retrospective study in Jordanian patients

OA Al Karsaneh, A Al Anber… - …, 2023 - diagnosticpathology.biomedcentral …
Background Human epidermal growth factor receptor 2 (HER2), a promising therapeutic
target, can be mutated, amplified, or overexpressed in different malignancies, including non …

Prevalence and clinicopathological associations of HER2 expression in non-small cell lung cancer: a retrospective study in Jordanian patients.

O Abu Al Karsaneh, A Al Anber, M ALQudah… - Diagnostic …, 2023 - europepmc.org
Background Human epidermal growth factor receptor 2 (HER2), a promising therapeutic
target, can be mutated, amplified, or overexpressed in different malignancies, including non …